Cancer Research Institute’s virtual Patient Immunotherapy Summit

Cancer Research Institute (CRI) shared on LinkedIn:

“”I was one of the first lung cancer patients to participate in a clinical trial with immunotherapy. Immediately, when I had my first infusion, I felt a difference,” says CRI ImmunoAdvocate Barry. “Something positive was going to happen.”

Discover Barry’s immunotherapy journey, during the Cancer Research Institute’s virtual Patient Immunotherapy Summit.”

Read further.
Source: Cancer Research Institute (CRI)/LinkedIn